Biocon obtains approval for diabetes drug Liraglutide in UK Ruchika Sharma28 March 2024 2:30 PM ISTBengaluru: Biocon Limited, a global biopharmaceuticals company, has announced that the Company has received approval from the Medicines and...
Biocon Biologics takes over biosimilars business from Viatris in over 70 countries Ruchika Sharma6 July 2023 11:36 AM ISTAll the biosimilar products commercialized by Viatris in various markets such as bGlargine (Semglee), bPegfilgrastim (Fulphila), bTrastuzumab...
Viatris sells global biosimilars business to Biocon Biologics for USD 3 billion Ruchika Sharma30 Nov 2022 11:23 AM ISTThe acquisition provides Biocon Biologics with direct commercial capabilities and supporting infrastructure in the advanced markets and several...
Biocon Biologics inks pact to provide cancer biosimilars to 30 countries in Africa, Asia Ruchika Sharma5 Feb 2021 3:09 PM ISTBengaluru: Biocon Biologics Ltd., a subsidiary of Biocon Ltd., has recently signed an agreement with the Clinton Health Access Initiative (CHAI) to...
